{"id":"af66edb098f00962a285f26dd163ab681e3c87d0182c99205bc3cd7333db6408","title":"MIT Technology Review’s The Download considers AI slop and CRISPR’s reach","argument":"MIT Technology Review published this edition of The Download on January 9, 2026. Its lead story previews Caiwei Chen’s effort to understand why some AI-generated videos feel objectionable while others strike viewers as compellingly weird, funny, or brilliant. Chen says conversations with video makers, a company creating tools for creators, and experts studying media and culture led her to think generative AI might not ruin everything after all. The excerpt does not give the full story’s reasoning, so how Chen reached that conclusion remains unknown here.\n\nThe newsletter also reports that a new CRISPR startup proposes an “umbrella approach” to testing and commercializing treatments, which it says could avoid costly new trials or approvals for every version. The newsletter frames this proposal against limited use of gene-editing drugs and discouragement in the field; it does not establish that regulators will ease up or that the startup’s approach will help more people. Other items preview debate over dietary guidelines, research on returns from public R&D spending, and stories about technology and culture.","topicIds":["investment-booms-and-busts","artificial-general-intelligence"],"domain":"other","claimType":"attributed reading","limits":"Text as retrieved on November 18, 2026; originally published January 9, 2026. The lead story is summarized from a brief newsletter preview, not its full text; the preview does not explain the basis for Chen’s conclusion. The newsletter reports the startup’s proposal but supplies no details here about its testing or commercial outcomes.","speaker":{"name":"MIT Technology Review","roleAtSource":"Publisher"},"source":{"title":"The Download: the case for AI slop, and helping CRISPR fulfill its promise","publisher":"MIT Technology Review","format":"Article","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","publishedAt":"2026-01-09T13:10:00Z","dateBasis":"Date from the publisher’s own records, through its API."},"evidence":[{"text":"Caiwei Chen says she spoke with video makers, a company creating tools for creators, and experts studying how new media becomes culture to understand her reaction to AI videos.","excerpt":"I spoke to the people making the videos, a company creating bespoke tools for creators, and experts who study how new media becomes culture.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"Chen says those conversations made her think generative AI might not end up ruining everything.","excerpt":"What I found convinced me that maybe generative AI will not end up ruining everything after all.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"The newsletter says a new startup proposes an “umbrella approach” to testing and commercializing treatments, which could avoid costly new trials or approvals for each version.","excerpt":"A new startup says the answer could be an “umbrella approach” to testing and commercializing treatments which could avoid costly new trials or approvals for every new version.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"The newsletter says gene-editing drugs have had limited commercial use and describes discouragement in the field.","excerpt":"there’s been only one gene-editing drug approved, and it’s been used commercially on only about 40 patients, all with sickle-cell disease.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"The newsletter says dietary guidelines influence food assistance programs and school lunches.","excerpt":"These guidelines are a big deal—they influence food assistance programs and school lunches, for example.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"The newsletter says economists’ conclusions across several recent papers share the view that government R&D is one of the better long-term investments it can make.","excerpt":"their conclusions share a bottom line: R&D is, in fact, one of the better long-term investments that the government can make.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"}],"sourceMedia":{"status":"unchecked","sourceUrl":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","checkedAt":null,"items":[]},"assumptions":[],"openQuestion":{"attribution":"Open question","text":"What did Chen’s conversations reveal about why some AI-generated videos feel objectionable while others seem funny or compelling?"},"whatWouldChangeView":{"attribution":"Change condition not recorded","text":""},"editorialComparisons":[],"live":{"title":"MIT Technology Review’s The Download considers AI slop and CRISPR’s reach","summary":"MIT Technology Review published this edition of The Download on January 9, 2026. Its lead story previews Caiwei Chen’s effort to understand why some AI-generated videos feel objectionable while others strike viewers as compellingly weird, funny, or brilliant. Chen says conversations with video makers, a company creating tools for creators, and experts studying media and culture led her to think generative AI might not ruin everything after all. The excerpt does not give the full story’s reasoning, so how Chen reached that conclusion remains unknown here.\n\nThe newsletter also reports that a new CRISPR startup proposes an “umbrella approach” to testing and commercializing treatments, which it says could avoid costly new trials or approvals for every version. The newsletter frames this proposal against limited use of gene-editing drugs and discouragement in the field; it does not establish that regulators will ease up or that the startup’s approach will help more people. Other items preview debate over dietary guidelines, research on returns from public R&D spending, and stories about technology and culture.","question":"What did Chen’s conversations reveal about why some AI-generated videos feel objectionable while others seem funny or compelling?","claims":[{"text":"Caiwei Chen says she spoke with video makers, a company creating tools for creators, and experts studying how new media becomes culture to understand her reaction to AI videos.","excerpt":"I spoke to the people making the videos, a company creating bespoke tools for creators, and experts who study how new media becomes culture.","support":"source-stated"},{"text":"Chen says those conversations made her think generative AI might not end up ruining everything.","excerpt":"What I found convinced me that maybe generative AI will not end up ruining everything after all.","support":"source-stated"},{"text":"The newsletter says a new startup proposes an “umbrella approach” to testing and commercializing treatments, which could avoid costly new trials or approvals for each version.","excerpt":"A new startup says the answer could be an “umbrella approach” to testing and commercializing treatments which could avoid costly new trials or approvals for every new version.","support":"source-stated"},{"text":"The newsletter says gene-editing drugs have had limited commercial use and describes discouragement in the field.","excerpt":"there’s been only one gene-editing drug approved, and it’s been used commercially on only about 40 patients, all with sickle-cell disease.","support":"source-stated"},{"text":"The newsletter says dietary guidelines influence food assistance programs and school lunches.","excerpt":"These guidelines are a big deal—they influence food assistance programs and school lunches, for example.","support":"source-stated"},{"text":"The newsletter says economists’ conclusions across several recent papers share the view that government R&D is one of the better long-term investments it can make.","excerpt":"their conclusions share a bottom line: R&D is, in fact, one of the better long-term investments that the government can make.","support":"source-stated"}],"limitations":["Text as retrieved on November 18, 2026; originally published January 9, 2026.","The lead story is summarized from a brief newsletter preview, not its full text; the preview does not explain the basis for Chen’s conclusion.","The newsletter reports the startup’s proposal but supplies no details here about its testing or commercial outcomes."],"mediaId":null,"correctionReason":null,"id":"af66edb098f00962a285f26dd163ab681e3c87d0182c99205bc3cd7333db6408","publicationId":"b4076a93-6c18-fbc4-b258-6a1772d254b2","version":1,"sourceUrl":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","sourceTitle":"The Download: the case for AI slop, and helping CRISPR fulfill its promise","publisher":"MIT Technology Review","publishedAt":"2026-01-09T13:10:00Z","originalPublished":{"value":"2026-01-09T13:10:00Z","precision":"instant","basis":"backfill:api_published"},"firstObservedAt":"2026-11-18T19:36:05.963Z","createdAt":"2026-11-18T21:23:09.763Z","historical":true,"entityIds":[],"topicIds":["investment-booms-and-busts","artificial-general-intelligence"],"media":[],"sourceMedia":{"status":"unchecked","sourceUrl":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","checkedAt":null,"items":[]},"editorialDecision":{"outcome":"accept","mediaId":null,"inputHash":"5067fa73e104c8294388b0ae6b2860a6b57f7bd712336b0b5bb22024cc03daf5","rubricVersion":"unrecorded","provider":"anthropic","model":"claude-opus-5-5","reasonCodes":["bridge_admitted_by_model","second_opinion_categorical"],"confidence":1,"decidedAt":"2026-11-18T19:36:00.520Z"},"provenance":{"textHash":"ffe98e7fc9a7c7335621c73204b64122187cd017e6e616b5003e3c4cbf33912a","observationId":"06cb5af2cec37874e203b95d7b0214f60003c4b7e942c7cfb7746ccb8c31b1ed","retrievedAt":"2026-11-18T19:38:01.558Z","kind":"publisher-page","preparer":{"model":"openai/gpt-6-luna","runId":"c1dc8946-797f-fc62-2cd9-01cbc39d0906"},"reviewer":{"model":"anthropic/claude-opus-5.5","runId":"ba41683c-3eef-ee2b-badd-2e3ea61d1c85"}},"audit":{"status":"passed","reviewedAt":"2026-11-18T21:18:58.324Z","model":"anthropic/claude-opus-5.5"}},"canonicalUrl":"https://escapemeridian.com/readings/mit-technology-review-s-the-download-considers-ai-slop-and-af66edb0","formats":{"html":"/readings/mit-technology-review-s-the-download-considers-ai-slop-and-af66edb0","markdown":"/readings/mit-technology-review-s-the-download-considers-ai-slop-and-af66edb0.md","json":"/readings/mit-technology-review-s-the-download-considers-ai-slop-and-af66edb0.json"},"attribution":"Headline and summary by Escape Meridian, prepared by Luna from the attributed source. A source check is not independent confirmation of the source’s claims.","maintainedGuideLinks":[],"conditions":[],"readerContext":{"version":"reader-context-v1","attribution":"Reference context selected by Escape Meridian; separate from source evidence. Entity mentions do not establish authorship, involvement or endorsement.","terms":[],"entities":[]},"researchQuestions":[],"withdrawn":false,"references":{"schemaVersion":1,"target":{"type":"reading","id":"af66edb098f00962a285f26dd163ab681e3c87d0182c99205bc3cd7333db6408","revision":"b4076a93-6c18-fbc4-b258-6a1772d254b2","revisionKind":"publication-id","title":"MIT Technology Review’s The Download considers AI slop and CRISPR’s reach","url":"https://escapemeridian.com/readings/mit-technology-review-s-the-download-considers-ai-slop-and-af66edb0"},"source":{"type":"source","id":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","revision":"ffe98e7fc9a7c7335621c73204b64122187cd017e6e616b5003e3c4cbf33912a","revisionKind":"sha256-source-text","title":"The Download: the case for AI slop, and helping CRISPR fulfill its promise","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/"},"status":"available","items":[],"next":null,"scope":"Explicit citations in public readings to this reading. Shared topics are not citations. Other record types need an explicit reference adapter."},"revisions":[{"id":"af66edb098f00962a285f26dd163ab681e3c87d0182c99205bc3cd7333db6408","title":"MIT Technology Review’s The Download considers AI slop and CRISPR’s reach","argument":"MIT Technology Review published this edition of The Download on January 9, 2026. Its lead story previews Caiwei Chen’s effort to understand why some AI-generated videos feel objectionable while others strike viewers as compellingly weird, funny, or brilliant. Chen says conversations with video makers, a company creating tools for creators, and experts studying media and culture led her to think generative AI might not ruin everything after all. The excerpt does not give the full story’s reasoning, so how Chen reached that conclusion remains unknown here.\n\nThe newsletter also reports that a new CRISPR startup proposes an “umbrella approach” to testing and commercializing treatments, which it says could avoid costly new trials or approvals for every version. The newsletter frames this proposal against limited use of gene-editing drugs and discouragement in the field; it does not establish that regulators will ease up or that the startup’s approach will help more people. Other items preview debate over dietary guidelines, research on returns from public R&D spending, and stories about technology and culture.","topicIds":["investment-booms-and-busts","artificial-general-intelligence"],"domain":"other","claimType":"attributed reading","limits":"Text as retrieved on November 18, 2026; originally published January 9, 2026. The lead story is summarized from a brief newsletter preview, not its full text; the preview does not explain the basis for Chen’s conclusion. The newsletter reports the startup’s proposal but supplies no details here about its testing or commercial outcomes.","speaker":{"name":"MIT Technology Review","roleAtSource":"Publisher"},"source":{"title":"The Download: the case for AI slop, and helping CRISPR fulfill its promise","publisher":"MIT Technology Review","format":"Article","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","publishedAt":"2026-01-09T13:10:00Z","dateBasis":"Date from the publisher’s own records, through its API."},"evidence":[{"text":"Caiwei Chen says she spoke with video makers, a company creating tools for creators, and experts studying how new media becomes culture to understand her reaction to AI videos.","excerpt":"I spoke to the people making the videos, a company creating bespoke tools for creators, and experts who study how new media becomes culture.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"Chen says those conversations made her think generative AI might not end up ruining everything.","excerpt":"What I found convinced me that maybe generative AI will not end up ruining everything after all.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"The newsletter says a new startup proposes an “umbrella approach” to testing and commercializing treatments, which could avoid costly new trials or approvals for each version.","excerpt":"A new startup says the answer could be an “umbrella approach” to testing and commercializing treatments which could avoid costly new trials or approvals for every new version.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"The newsletter says gene-editing drugs have had limited commercial use and describes discouragement in the field.","excerpt":"there’s been only one gene-editing drug approved, and it’s been used commercially on only about 40 patients, all with sickle-cell disease.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"The newsletter says dietary guidelines influence food assistance programs and school lunches.","excerpt":"These guidelines are a big deal—they influence food assistance programs and school lunches, for example.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"},{"text":"The newsletter says economists’ conclusions across several recent papers share the view that government R&D is one of the better long-term investments it can make.","excerpt":"their conclusions share a bottom line: R&D is, in fact, one of the better long-term investments that the government can make.","url":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","relationship":"Source-stated"}],"sourceMedia":{"status":"unchecked","sourceUrl":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","checkedAt":null,"items":[]},"assumptions":[],"openQuestion":{"attribution":"Open question","text":"What did Chen’s conversations reveal about why some AI-generated videos feel objectionable while others seem funny or compelling?"},"whatWouldChangeView":{"attribution":"Change condition not recorded","text":""},"editorialComparisons":[],"live":{"title":"MIT Technology Review’s The Download considers AI slop and CRISPR’s reach","summary":"MIT Technology Review published this edition of The Download on January 9, 2026. Its lead story previews Caiwei Chen’s effort to understand why some AI-generated videos feel objectionable while others strike viewers as compellingly weird, funny, or brilliant. Chen says conversations with video makers, a company creating tools for creators, and experts studying media and culture led her to think generative AI might not ruin everything after all. The excerpt does not give the full story’s reasoning, so how Chen reached that conclusion remains unknown here.\n\nThe newsletter also reports that a new CRISPR startup proposes an “umbrella approach” to testing and commercializing treatments, which it says could avoid costly new trials or approvals for every version. The newsletter frames this proposal against limited use of gene-editing drugs and discouragement in the field; it does not establish that regulators will ease up or that the startup’s approach will help more people. Other items preview debate over dietary guidelines, research on returns from public R&D spending, and stories about technology and culture.","question":"What did Chen’s conversations reveal about why some AI-generated videos feel objectionable while others seem funny or compelling?","claims":[{"text":"Caiwei Chen says she spoke with video makers, a company creating tools for creators, and experts studying how new media becomes culture to understand her reaction to AI videos.","excerpt":"I spoke to the people making the videos, a company creating bespoke tools for creators, and experts who study how new media becomes culture.","support":"source-stated"},{"text":"Chen says those conversations made her think generative AI might not end up ruining everything.","excerpt":"What I found convinced me that maybe generative AI will not end up ruining everything after all.","support":"source-stated"},{"text":"The newsletter says a new startup proposes an “umbrella approach” to testing and commercializing treatments, which could avoid costly new trials or approvals for each version.","excerpt":"A new startup says the answer could be an “umbrella approach” to testing and commercializing treatments which could avoid costly new trials or approvals for every new version.","support":"source-stated"},{"text":"The newsletter says gene-editing drugs have had limited commercial use and describes discouragement in the field.","excerpt":"there’s been only one gene-editing drug approved, and it’s been used commercially on only about 40 patients, all with sickle-cell disease.","support":"source-stated"},{"text":"The newsletter says dietary guidelines influence food assistance programs and school lunches.","excerpt":"These guidelines are a big deal—they influence food assistance programs and school lunches, for example.","support":"source-stated"},{"text":"The newsletter says economists’ conclusions across several recent papers share the view that government R&D is one of the better long-term investments it can make.","excerpt":"their conclusions share a bottom line: R&D is, in fact, one of the better long-term investments that the government can make.","support":"source-stated"}],"limitations":["Text as retrieved on November 18, 2026; originally published January 9, 2026.","The lead story is summarized from a brief newsletter preview, not its full text; the preview does not explain the basis for Chen’s conclusion.","The newsletter reports the startup’s proposal but supplies no details here about its testing or commercial outcomes."],"mediaId":null,"correctionReason":null,"id":"af66edb098f00962a285f26dd163ab681e3c87d0182c99205bc3cd7333db6408","publicationId":"b4076a93-6c18-fbc4-b258-6a1772d254b2","version":1,"sourceUrl":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","sourceTitle":"The Download: the case for AI slop, and helping CRISPR fulfill its promise","publisher":"MIT Technology Review","publishedAt":"2026-01-09T13:10:00Z","originalPublished":{"value":"2026-01-09T13:10:00Z","precision":"instant","basis":"backfill:api_published"},"firstObservedAt":"2026-11-18T19:36:05.963Z","createdAt":"2026-11-18T21:23:09.763Z","historical":true,"entityIds":[],"topicIds":["investment-booms-and-busts","artificial-general-intelligence"],"media":[],"sourceMedia":{"status":"unchecked","sourceUrl":"https://www.technologyreview.com/2026/01/09/1130953/the-download-the-case-for-ai-slop-and-helping-crispr-fulfill-its-promise/","checkedAt":null,"items":[]},"editorialDecision":{"outcome":"accept","mediaId":null,"inputHash":"5067fa73e104c8294388b0ae6b2860a6b57f7bd712336b0b5bb22024cc03daf5","rubricVersion":"unrecorded","provider":"anthropic","model":"claude-opus-5-5","reasonCodes":["bridge_admitted_by_model","second_opinion_categorical"],"confidence":1,"decidedAt":"2026-11-18T19:36:00.520Z"},"provenance":{"textHash":"ffe98e7fc9a7c7335621c73204b64122187cd017e6e616b5003e3c4cbf33912a","observationId":"06cb5af2cec37874e203b95d7b0214f60003c4b7e942c7cfb7746ccb8c31b1ed","retrievedAt":"2026-11-18T19:38:01.558Z","kind":"publisher-page","preparer":{"model":"openai/gpt-6-luna","runId":"c1dc8946-797f-fc62-2cd9-01cbc39d0906"},"reviewer":{"model":"anthropic/claude-opus-5.5","runId":"ba41683c-3eef-ee2b-badd-2e3ea61d1c85"}},"audit":{"status":"passed","reviewedAt":"2026-11-18T21:18:58.324Z","model":"anthropic/claude-opus-5.5"}}}],"audits":[{"publicationId":"b4076a93-6c18-fbc4-b258-6a1772d254b2","verdict":"passed","findings":[{"dimension":"attribution","status":"pass","explanation":"This is one newsletter issue commenting in its own words, not a bare listing. The reading attributes it to MIT Technology Review's The Download, credits the AI slop piece to Caiwei Chen, and attributes the umbrella approach to the startup as relayed by the newsletter.","excerpt":"This is today's edition of The Download, our weekday newsletter"},{"dimension":"summary","status":"pass","explanation":"The reading leads with Chen's reconsideration of AI-generated videos and her tentative conclusion, and it states that the preview gives no reasoning. CRISPR is placed next to gene-editing drugs, so a general reader can follow. The reading omits Chen's own blunt starting view and her experience of being fooled by the rabbit video; this is a minor loss of voice, not a fidelity failure. The question follows from the gap in the evidence.","excerpt":"My first reaction was that, broadly speaking, all of this sucked."},{"dimension":"date","status":"pass","explanation":"The reading's January 9, 2026 matches the UTC day of originalPublished, 2026-01-09T13:10Z. The kind is publisher-page, so no archive disclosure is needed. The reading presents no later events and frames the startup's bet as a proposal, not an outcome.","excerpt":null},{"dimension":"support","status":"pass","explanation":"Each claim matches its quoted source text. The reading keeps 'maybe' and 'could' as hedges and states that the newsletter does not establish that regulators will ease up or that the approach will help people.","excerpt":"A new CRISPR startup is betting regulators will ease up on gene-editing"},{"dimension":"media","status":"pass","explanation":"No media was selected, and no verified candidates were supplied.","excerpt":null}],"createdAt":"2026-11-18T21:18:58.324Z","model":"anthropic/claude-opus-5.5"}],"correctionUrl":"https://escapemeridian.com/corrections/"}